10-K · February 26, 2026
Enovis Corporation reported a revenue of $2.248 billion for the year ended December 31, 2025, reflecting a 6.7% increase from the previous year. The company faced operating losses of approximately $1.124 billion,…
Earnings analysis · 10-Q
ENOV earnings analysis
Filed May 7, 2026 · Our reading of the company's report
The latest report
Enovis Corporation's Q1 2026 results showed revenue of $589 million, which exceeded the consensus estimate by 3%. Gross profit improved to $365.5 million, pushing the gross margin to 62%. However, the company reported a…
Read full summary
Enovis Corporation's Q1 2026 results showed revenue of $589 million, which exceeded the consensus estimate by 3%. Gross profit improved to $365.5 million, pushing the gross margin to 62%. However, the company reported a net loss of $8.5 million, significantly narrower than losses reported in the previous year, but still missing the expected EPS of $0.81. The company reaffirmed its full-year revenue guidance of $2.31 billion to $2.37 billion despite facing various operational challenges.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.15
- Segment
- Prevention & Recovery
- Segment
- Reconstructive
What stood out
-
Revenue Exceeded Estimates
Revenue for Q1 2026 was $589 million, surpassing the consensus estimate of $571.6 million by 3%.
-
Strong Gross Profit Growth
Gross profit improved to $365.5 million, an increase of 10.0% from $332.2 million in Q1 2025.
-
Adjusted EBITDA Growth
Adjusted EBITDA rose to $103.6 million, up from $87.1 million in Q1 2025, reflecting strong operational performance.
-
Improvement in Margins
Gross margin increased to 62.0%, up from 59.4% in Q1 2025.
-
Reconstructive Segment Growth
The Reconstructive segment saw net sales increase by $30.8 million, or 10.8%, during the period.
-
Cash Flow Increase
Operating cash flow improved to $24.0 million compared to a negative $1.6 million in the prior year.
What to watch
-
Continued Net Losses
Net loss for Q1 2026 was $8.5 million, although improved from a loss of $55.7 million in Q1 2025.
-
Divestiture Impact
Sales decreased by $12.7 million due to the October 2025 divestiture of the Dr. Comfort Footcare Solutions product line.
-
Potential Macroeconomic Headwinds
Management highlighted risks related to geopolitical tensions and inflation affecting operational stability.
Management's outlook
Full-year 2026 guidance reaffirmed with expected organic revenue growth between 4-6%.
Earlier filings 4
10-Q · November 6, 2025
Enovis Corporation reported Q3 2025 results showing stronger-than-expected revenue and EPS, significantly surpassing consensus estimates. Although gross margins improved, the company incurred substantial goodwill…
10-Q · August 7, 2025
Enovis Corporation reported its Q2 2025 results showing a significant increase in revenue and EPS compared to both the prior quarter and the same quarter last year. Notably, revenue reached $565 million, a 7.6% increase…
10-Q · May 8, 2025
Enovis Corporation's Q1 2025 results reflect a strong recovery with revenue increasing by 8.2% year-over-year to $558.8 million, driven primarily by growth in the Reconstructive segment. Gross and operating margins…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.